Spelman, T., Harvrdova, E.K., Horakova, D., Izquierdo, G., Kalincik, T., Lugaresi, A., et al. (2018). Comparative effectiveness of switching to natalizumab or fingolimod after relapse on first-line relapsing-remitting multiple sclerosis therapy: propensity score matching analysis from the MSBase registry. MULTIPLE SCLEROSIS, 24, 25-26.
Comparative effectiveness of switching to natalizumab or fingolimod after relapse on first-line relapsing-remitting multiple sclerosis therapy: propensity score matching analysis from the MSBase registry
Lugaresi, AWriting – Review & Editing
;
2018
File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
